ANZUP Cancer Trials Group Ltd is a collaborative, national and international, urogenital and prostate cancer, clinical trials, and research group. The organisational structure of ANZUP reflects its corporate governance and operational areas of responsibility.
The Board comprises the Directors of the Company and is responsible for financial management, corporate governance, reporting and compliance. The Board consists of five elected Directors and three Appointed Directors. The Board meets by teleconference approximately once every 2 months and face-to-face several times per year.
Finance and Audit Committee
A subcommittee of the Board. Its main objectives are to assist the Board in the discharge of its responsibility to exercise due care, diligence and skill; and to provide a formal forum for financial management, compliance and control.
Fundraising and Promotion Subcommittee
A subcommittee of the Board. Its main objectives are to identify and pursue opportunities for additional revenue through fundraising and production of relevant marketing materials for ANZUP.
The secretariat comprises an Executive Officer and a Project Officer. The company’s registered office is located in Sydney.
The SAC provides a mechanism for the development of new concept proposals, prioritisation and incorporation of key translational and research questions into active and proposed trials. It also includes the monitoring of ongoing trials and establishing research priorities.
The SAC is advised by 4 disease specific subcommittees (Prostate; Renal; Germ Cell; Bladder) and 2 non-disease-specific subcommittees (Quality of Life & Supportive Care and Translational Research). The disease-specific subcommittees are responsible for oversight of trials within their portfolios, as well as development of new trial concepts. The non-disease-specific subcommittees are also involved in trial development and management in order to ensure that maximum value is added to every trial.
ANZUP’s Consumer Advisory Panel (CAP) provides a mechanism for advice to be offered on specific studies, general research directions, and priorities from a consumer perspective. The CAP also provide a conduit for communication from ANZUP back to the community in order to promote research and engage community support.
Operations Executive Committee
This committee consists of representatives from ANZUP and from the NHMRC Clinical Trials Centre at the University of Sydney. The Committee is responsible for oversight of trial and group operations. This Committee meets by teleconference approximately once per month.
Independent Data Monitoring Committee
Terms of reference for the IDMC have been drafted and discussions are underway with other cooperative cancer clinical trials groups to share resources for this purpose. It is anticipated that the IDMC will have oversight of multiple clinical trials.
Trial Management Committees
Each trial has a TMC that meets approximately quarterly by teleconference to ensure oversight of the trial.